A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
Clinisys has released an AI Innovation Roadmap to connect laboratory data, analytics, and automation, supporting workflow ...
Researchers developed a blood test using 10 biomarkers to help predict chronic disease risk and functional decline in adults.
The US DHS added three BGI-linked genomics companies to the UFLPA Entity List, imposing import restrictions on certain lab ...
Scipher Medicine plans early physician access for PrismTcell, a blood test to predict abatacept response in rheumatoid ...
LITMUS studies published in The Lancet and Nature Medicine validate blood and imaging tests for MASLD and MASH, reducing ...
A new Pennsylvania law mandates no-cost coverage of blood-based colorectal cancer screening for 2 million residents, aligning ...
A study found HPV testing detected high-grade cervical lesions missed by cytology in a cohort screened with CoSara’s assay.
OGT releases an RNA-based NGS panel for AML, enabling detection of leukemia-associated gene fusions at 1% tumor cell levels.
Malignant mesothelioma is a rare, life-threatening cancer that develops in the thin tissue lining internal organs, with more ...
Curiox Biosystems expands its leadership team and forms a Strategic Advisory Board to support growth of its centrifuge-free ...
Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results